Cerapedics Stock
CeraPedics is a medical device company that focuses on developing and commercializing novel osteobiologic products.
Sign up today and learn more about Cerapedics Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Cerapedics Stock
Cerapedics is an orthobiologics company focused on developing its proprietary biomimetic small peptide molecule (P-15) for commercialization in spinal applications. The company was founded in 2001 and is headquartered in Westminster, Colorado.
Funding History
| February 2007 | $12.3M |
|---|---|
| October 2007 | $16.4M |
| April 2009 | $15.0M |
| February 2012 | $3.0M |
| July 2012 | $19.0M |
| April 2014 | $9.0M |
| February 2015 | $4.0M |
| April 2015 | $4.0M |
| September 2016 | $11.0M |
| April 2017 | $20.0M |
| July 2018 | $22.0M |
| January 2019 | $45.0M |
| March 2022 | $25.0M |
Management
Founder
Andrew Tofe
Board of Directors
Chau Khuong
President & COO
Jeffrey G. Marx
CEO
Glen A. Kashuba
Chairman of the Board of Directors
Jonathan Silverstein
Press
patents - Apr, 15 2024
Peptide-coated calcium phosphate particlespatents - Apr, 15 2024
Devices and methods for ameliorating implant-induced inflammationbiospace - Apr, 6 2024
Cerapedics to Present at the 42nd Annual J.P. Morgan Healthcare Conferencebizjournals - Jan, 27 2024
Colorado medtech company grows local HQ, plans to hire 60 ...dovepress - Jan, 27 2024
Best Practice: Informed Consent for Spine Procedures | JPREquityZen Recognized As:
